Cargando…
The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to tre...
Autores principales: | Muro, Koji, Toda, Naohiro, Yamamoto, Shinya, Yanagita, Motoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946495/ https://www.ncbi.nlm.nih.gov/pubmed/32999232 http://dx.doi.org/10.2169/internalmedicine.5461-20 |
Ejemplares similares
-
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023) -
Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2018) -
CTGF in kidney fibrosis and glomerulonephritis
por: Toda, Naohiro, et al.
Publicado: (2018) -
Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximab
por: Ha, Austin Y., et al.
Publicado: (2016) -
Membranoproliferative glomerulonephritis with essential cryoglobulinemia
por: Satish, S., et al.
Publicado: (2008)